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Abstract
Background: Non-communicable diseases, intended as the results of a combination of inherited, environmental and
biological factors, kill 40 million people each year, equivalent to roughly 70% of all premature deaths globally. The
possibility that manufactured nanoparticles (NPs) may affect cardiac performance, has led to recognize NPs-exposure not
only as a major Public Health concern, but also as an occupational hazard. In volunteers, NPs-exposure is problematic to
quantify. We recently found that inhaled titanium dioxide NPs, one of the most produced engineered nanomaterials,
acutely increased cardiac excitability and promoted arrhythmogenesis in normotensive rats by a direct interaction
with cardiac cells. We hypothesized that such scenario can be exacerbated by latent cardiovascular disorders such
as hypertension.
Results: We monitored cardiac electromechanical performance in spontaneously hypertensive rats (SHRs) exposed to
titanium dioxide NPs for 6 weeks using a combination of cardiac functional measurements associated with toxicological,
immunological, physical and genetic assays.
Longitudinal radio-telemetry ECG recordings and multiple-lead epicardial potential mapping revealed that atrial activation
times significantly increased as well as proneness to arrhythmia. At the third week of nanoparticles administration,
the lung and cardiac tissue encountered a maladaptive irreversible structural remodelling starting with increased pro-
inflammatory cytokines levels and lipid peroxidation, resulting in upregulation of the main pro-fibrotic cardiac genes.
At the end of the exposure, the majority of spontaneous arrhythmic events terminated, while cardiac hemodynamic
deteriorated and a significant accumulation of fibrotic tissue occurred as compared to control untreated SHRs. Titanium
dioxide nanoparticles were quantified in the heart tissue although without definite accumulation as revealed by particle-
induced X-ray emission and ultrastructural analysis.
Conclusions: The co-morbidity of hypertension and inhaled nanoparticles induces irreversible hemodynamic impairment
associated with cardiac structural damage potentially leading to heart failure. The time-dependence of exposure indicates
a non-return point that needs to be taken into account in hypertensive subjects daily exposed to nanoparticles.
Keywords: Titanium dioxide nanoparticles, Nanotoxicology, Cardiac electrophysiology, Cardiac fibrosis, Arrhythmias
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Background
Communicable and non-communicable diseases increase
at the same rate in low and high-income countries occur-
ring among the same patient populations, and it is funda-
mental to define an effective and sustainable action [1]. For
example, the World Heart Federation counts 970 million
people suffering from high blood pressure that is one of the
most important causes of death with a still growing trend.
Many questions involving the effects of engineered nano-
materials on the environment, as well as human health,
have been raised and need to be addressed [2]. Manufac-
tured nanoparticles have become a new component of the
air we breathe [3]. Since the heart and the lungs are intim-
ately linked, it is difficult to identify the specific susceptibil-
ity of either organ to the effects of nanoparticles (NPs) [4].
It is possible to better define the impact of particle matter
(PM) on individual organ impairment or disease [5, 6]
through the use of animal models. Recently, in order to fur-
ther clarify the relationships between fine particles and car-
diopulmonary diseases, the spontaneously hypertensive rat
(SHR) has been widely used as a model of cardiovascular
hypertension for researches on toxicology and pathogenesis
of cardiovascular adverse effects of exposure to PM [7].
Limited experimental evidence from cardiopulmonary-
compromised animal models has shown increased mortal-
ity from chronic exposure to simulated particle/gaseous
urban air pollution in SHR [8]. Chronic systemic hyperten-
sion and associated cardiomyopathy may increase the sus-
ceptibility to PM-induced morbidity. In fact, in control
SHR the ECG showed a depression in ST-segment area
which was not present in Wistar Kyoto (WKY) rats and a
further depression in ST-segment area in SHR during the
first and second days of PM exposure. This enhanced de-
pression was less evident following 3 days of exposure, per-
haps suggesting adaptive changes [9].
The first study to report long-term cardiovascular toxicity
of an inhaled engineered nanomaterial, clearly demon-
strated that long-term exposure to inhaled nickel NPs can
induce oxidative stress and inflammation, not only in the
lung but also in the cardiovascular system [10]. Recent data
showed that long-term silica inhalation in rat, at realistic
concentrations, induced very low systemic toxicity and neg-
ligible pulmonary fibrogenicity [11].
Titanium dioxide (TiO2) is one of the most widely pro-
duced engineered nanomaterials. As consumption grows
the chance of population exposure to fine or ultrafine TiO2
increases. In 2007 the National Institute for Occupational
Safety and Health (NIOSH) estimated 68.000 workers in
U.S. directly in contact with TiO2 pigments, with an esti-
mated production of TiO2 of 1.45 million metric tons / year
(https://www.cdc.gov/niosh/docs/2011-160/pdfs/2011-160.
pdf) and the demand of TiO2 increases exponentially
worldwide. Compared to the high risk of heart disease by
PM exposure, the TiO2 effects are still partially known [12].
It is estimated 1.56 billion hypertensive people by 2025
[13]; nowadays, one third of the population between 15 and
69 years old suffer from high blood pressure, while half of
them is either not conscious of the hypertension nor under-
goes medical treatment [14]. It is thus considerable that a
similar percentage of workers daily exposed to TiO2-NPs
suffers of hypertension. In 2011, the NIOSH conducted a
systematic review of TiO2 health effects from epidemio-
logic, animal, and in vitro studies and defined a quantitative
risk assessment. In fact, exposure limits of 2.4mg/m3 for
fine TiO2 and 0.3mg/m
3 for ultrafine TiO2 were recom-
mended, as time-weighted average concentrations for up to
10 h per day during a 40-h work/week [15]. Subjects with
underlying health issues such as asthma and hypertension
may be at increased risk of TiO2-NPs toxicity [16]. A sig-
nificant association between inhalable TiO2-NPs exposure
and declines in pulmonary function has been demon-
strated, as well as increase in blood pressure, especially in
small airways functions and systolic blood pressure in
healthy workers at the end of shift [17]. Exposure of rats, by
intra-tracheal instillation, to a well-dispersed suspension of
ultra-fine TiO2-NPs caused dose-dependent pulmonary
damage and inflammation, which persisted 42 days post-
exposure [2]. Another work demonstrated that exposures
to nano sized TiO2 had no significant long-term adverse
pulmonary effects, even if acute levels of inflammation and
cytotoxicity were observed for TiO2-NPs, at the highest
dose of 5mg/kg, 1 day post-exposure [18]. We recently
showed that a single acute intra-tracheal instillation of
TiO2-NPs in normotensive animals, induces cardiac elec-
trophysiological alterations especially in the repolarization
phase, in both isolated cardiomyocytes and in vivo rat heart,
giving rise to a pro-arrhythmic substrate [19] due to the dir-
ect formation of nano pores across cell membrane [20]. It
also has been demonstrated that, when SHR and WKY rats
were exposed to the same dose of fine particles including
metallic elements such as Fe, Mg, Zn, Pb and Cu, the lung
injury in SHR was greater than in WKY rats, due to an in-
crease in cytokines [21], and rats with cardiopulmonary dis-
eases were more susceptible than healthy rats [22].
The aim of the present study was to investigate the ef-
fects of subchronical exposure to TiO2-NPs on cardiac
structure and electromechanical performance in SHRs,
being aware that TiO2-NPs can rapidly translocate from
the lung into the bloodstream and finally to the heart [19].
Here, we demonstrated a pathological cardiac remodeling
associated with an increment of spontaneous arrhythmic
events mainly including sinus pauses and atria-ventricular
blocks (AV blocks), changes in conduction velocity, and
worsened hemodynamic performance. Interestingly, our
approach identified a time-point characterized by cardiac
and pulmonary inflammatory response, nanotoxicity and
up-regulation of genes deputed to control collagen depos-
ition in the heart, ultimately resulting in an irreversible
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increment of diffuse cardiac fibrosis compared to the un-
treated SHRs.
Results
The experimental design and measurements performed
in the various animal groups are summarized in Fig. 1.
Telemetry-ECG study
Electrocardiographic wave and interval durations showed
only time-dependent effects as illustrated in Fig. 2. Atrial
activation (P wave duration) in NPs exposed SHRs was re-
duced at the 6th week and the end of the longitudinal
protocol (7th week) compared to the first week (Fig. 2a).
We did not observe significant differences for PQ seg-
ment, QRS complex and QTc (Fig. 2b, c and e). RR inter-
val was significantly reduced only at the end of the
experimental protocol in the treated animals (Fig. 2d).
The heart rate variability, evaluated as standard devi-
ation of RR interval (SDRR), increased only at final stage
in both groups (Fig. 3a), while no differences were seen in
the root mean square of successive RR interval square dif-
ferences (r-MSSD) value (Fig. 3b). ECG-telemetry analysis
revealed different types of arrhythmic events (Add-
itional file 1: Figure S1). Arrhythmia quantification dem-
onstrated that sinus pauses and AV blocks significantly
increased in TiO2-NPs group in comparison with control
(CTRL) group only after the 6th instillation (nine and
sixteen-fold increase, respectively; Fig. 3c and d). This in-
crease disappeared when TiO2 treatment was suspended.
Instead, supraventricular and ventricular arrhythmias were
similar in the two experimental groups during the entire
protocol (data not shown).
Hemodynamic study
The heart rate measured under anesthesia was similar in
both groups as well as systolic and diastolic arterial blood
pressure, and left ventricular systolic pressure (LVSP)
whose values were coherent with the degree of hyperten-
sion expected in 19-week old SHR (Table 1). Compared
with CTRL animals, TiO2-NP rats exhibited a global
Fig. 1 Study population and experimental protocol. Flowchart describing the number of animals subjected to the different experimental procedures
before and after intra-tracheal instillation of saline solution (CTRL group) or saline solution added with TiO2, at a final concentration of 2mg/kg (TiO2-NP
group). * timepoints for oxidative stress and inflammation; § timepoints for real-time PCR analysis; # timepoints for PIXE. For more details see “Outline of
the experimental protocols” section
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deterioration of hemodynamic performance, as indicated
by the significant increase in the left ventricular (LV) end-
diastolic pressure (+ 28%, LVEDP, Table 1), the decrement
in the maximal rate of LV pressure rise (− 15%, +dP/dtmax,
Table 1) and decline (− 15%, −dP/dtmax, Table 1), and the
marked prolongation of isovolumic contraction time (+
10%, IVCT, Table 1).
Epicardial mapping study
In-vivo electrophysiological parameters were evaluated by
means of epicardial multiple leads recording. Cardiac excit-
ability remained unchanged (Fig. 4b-d) during the entire
protocol while refractoriness decreased at the 6th week in
the CTRL group and then completely recovered (7th week)
to the values measured at the beginning of the experimen-
tal protocols (Fig. 4a). As compared to CTRL, the treat-
ment induced a significant decrease of ventricular
conduction velocity as well as anisotropy ratio by about
25% after first instillation (Fig. 4e and g). Afterwards the dif-
ferences between the two groups disappeared. A time-
dependent increment of longitudinal conduction velocity
(CVl) was observed in the TiO2-NP group at the 6th week.
After 1 week of recovery (7th week) CVl and transverse
conduction velocity (CVt) decreased in both groups (Fig. 4e
and f). Arrhythmia inducibility in TiO2-NP rats displayed




Fig. 2 Electrocardiographic waveform and interval durations. Basic electrophysiological parameters evaluated in CTRL (triangles) and TiO2-NPs treated
(square) animals. a P wave duration (ms). b PQ segment duration (ms). c QRS complex duration (ms). d RR interval duration (ms). e QTc duration (ms).
Kruskal-Wallis (post hoc analyses: Dunn’s multiple comparison) was performed and statistical significance was set at p< 0.05. * vs corresponding 1° week; #
vs corresponding 3° week. Data are represented as median and interquartile range (IQR)
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value at the end of experimental protocol after 1 week of
suspended treatment (data not shown).
Tibial length, cardiac anatomy and morphometric analysis
Body weight (BW) at sacrifice was similar between
the two groups, while tibial length and left ventricular
weight (LVW) were significantly reduced in TiO2-NP
rats (− 7% for both parameters; Table 2) showing a
reduced growth. LV wall thickness, chamber diameter,
chamber length, and LVW/BW were not different be-
tween the two groups. Conversely, LV mass was sig-
nificantly decreased (− 7%) and LV chamber volume
markedly increased (+ 30%), causing a reduction in
LV mass/chamber volume (− 23%; p = 0.07), in TiO2-
NP rats in comparison with CTRL (Table 2). In
addition, Masson’s trichrome staining demonstrated
that TiO2-NP rats displayed an increased volume
fraction of total fibrosis in the LV myocardium (Fig. 5)
mostly due to a significant increase in diffuse fibrosis
(+ 64%; Table 2).
Titanium dioxide quantification
We demonstrated that at the final stage (7th week), the
lung level of TiO2 increased by about 280% as com-
pared with the value measured after the first intra-
tracheal instillation (mean values: 1st week 1093 ± 571
ppm; 7th week 4232 ± 1403 ppm, p < 0.05) while TiO2-
NPS were practically absent in trachea (mean values:
1st week 900 ± 230 ppm; 7th absent). Conversely, heart
a b
c d
Fig. 3 Heart rate variability indexes and arrhythmia evaluation. Heart rate variability parameters and spontaneous arrhythmic events in CTRL (triangles) and
TiO2-NP (square) groups. a SDRR duration (ms). b r-MSSD duration (ms). c Sinus pauses (SP, number of events). d Atrio-ventricular blocks (AV block, number
of events). Kruskal-Wallis (post hoc analyses: Dunn’s multiple comparison’s) was performed and statistical significance was set at p< 0.05. ● vs CTRL; * vs
corresponding 1° week; # vs corresponding 3° week; § vs corresponding 6° week. Data are represented as median and IQR
Table 1 Hemodynamic study
CTRL (n = 9) TiO2-NP (n = 11)
Heart rate (beats/min) 188 ± 5 190 ± 5
Systolic arterial BP (mmHg) 197.5 ± 2.12 198.16 ± 7.08
Diastolic arterial BP (mmHg) 122.4 ± 4.36 123.0 ± 4.92
LVSP (mmHg) 195.9 ± 2.90 195.4 ± 5.96
LVEDP (mmHg) 6.51 ± 0.55 8.32 ± 0.64*
+dP/dtmax (mmHg/s) 9639.6 ± 86.37 8190.1 ± 264.5*
-dP/dtmax (mmHg/s) − 7790.6 ± 117.7 − 6608.2 ± 91.28*
IVCT (s) 0.020 ± 0.0002 0.022 ± 0.0003*
Values are means ± standard error of the mean (SEM)
Hemodynamic measurements were performed at 7th week, before sacrifice.
Unpaired Student’s t-test
BP blood pressure, LVSP left ventricular systolic pressure, LVEDP left ventricular
end-diastolic pressure, +dP/dtmax maximal rate of left ventricular (LV) pressure
rise, −dP/dtmax maximal rate of LV pressure decline, IVCT isovolumic
contraction time
*p < 0.05 vs CTRL
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tissue TiO2 level remained high, although without a
definite accumulation (mean values: 1st week 156 ± 37
ppm; 7th week 116 ± 16 ppm, n.s.)
Titanium dioxide detection
We found the presence of TiO2-NPs in both, the lungs
(Fig. 6) and the hearts (Fig. 7). In particular, several NPs
aggregates were found free in the alveolar space (Add-
itional file 2: Figure S2), in the interstitial space sur-
rounding alveolar capillary (Fig. 6c and d) and inside the
cells (Fig. 6e and f) as in alveolar cells displaying macro-
phagic/autophagic features (Fig. 6b). Morphologic evi-
dence provided by Transmission Electron Microscopy
(TEM) suggested that in the heart NPs left the capillary






Fig. 4 Cardiac refractoriness, excitability, anisotropic conduction velocities and arrhythmia induction. Electrophysiological parameters and the index of
arrhythmia inducibility in CTRL (triangles) and TiO2-NPs treated (squares) animals. a Effective refractory period (ERP, ms). b Rheobase (μA). c Chronaxie (ms).
d Threshold intensity for a 1ms duration impulse (μA). e ventricular conduction velocities along fiber (CVl, m/s). f ventricular conduction velocities across
fiber (CVt, m/s). g ventricular conduction velocities ratio (CVl/CVt). Kruskal-Wallis (post hoc analyses: Dunn’s multiple comparison) was performed and
statistical significance was set at p< 0.05. ● vs CTRL; * vs corresponding 1° week; # vs corresponding 3° week; § vs corresponding 6° week. Data are
represented as median and interquartile range (IQR)
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(Fig. 7b-d), penetrated the sarcolemma and reached the
myoplasm by establishing intimate contact with myofi-
brils and mitochondria (Fig. 7e and f).
Oxidative stress and inflammation
Lipid peroxidation analysis in cardiac and lung tissues dem-
onstrated that at the 3rd week the Thiobarbituric acid re-
active substances (TBARS) level significantly increased in
TiO2-NP rats compared to the 1st week of treatment, dis-
playing the maximum value (Fig. 8a, Additional file 3: Fig-
ure S3). Similarly, significant alterations were observed in
cardiac tissue at the 3rd week for Interleukin-6 (IL-6) and
Monocyte Chemoattractant Protein-1 (MCP-1) (Fig. 8b
and c). To note, tissue inhibitor metalloproteinase 1
(TIMP-1) levels increased as well at the 3rd week (Fig. 8d).
The treatment induced approx. 50% increment of all cyto-
kines at the 3rd week although the difference became statis-
tically significant only for TIMP-1.
Gene expression analysis
The expression of different genes related to myocardial fi-
brosis was assessed in the rat hearts, revealing that at the
3rd week TiO2-NPs instillation the expression of different
collagen isoform genes (namely COL1A2, COL3A1,
COL4A1) were definitively upregulated in treated animals
Table 2 Tibial length, cardiac anatomy and morphometric
analysis
CTRL (n = 9) TiO2-NP (n = 11)
Tibial length (mm) 38.2 ± 0.95 35.7 ± 0.25 *
BW (g) 359.3 ± 6.47 356.1 ± 5.70
LVW (mg) 1200 ± 25.50 1119.13 ± 27.91 *
LVW/BW (mg/g) 3.39 ± 0.10 3.16 ± 0.11
LV mass (mm3) 1132.1 ± 24.06 1055.8 ± 26.33 *
LV wall thickness (mm) 2.28 ± 0.09 2.26 ± 0.06
LV chamber diameter (mm) 7.43 ± 0.40 7.68 ± 0.25
LV chamber length (mm) 15.44 ± 0.50 15.11 ± 0.42
LV chamber volume (mm3) 361.3 ± 38.16 469.3 ± 31.29 *
LV mass/chamber volume 3.11 ± 0.33 2.39 ± 0.16
Total fibrosis (%) 7.64 ± 1.11 15.44 ± 3.09 *
Diffuse Fibrosis (%) 4.24 ± 0.82 11.69 ± 3.18 *
Perivascular Fibrosis (%) 3.59 ± 0.49 4.69 ± 0.45
Values are means ± SEM
Unpaired Student’s t-test
BW body weight measured before sacrifice, LV left ventricular, LVW left
ventricular weight
*p < 0.05 vs CTRL
a b
c d
Fig. 5 Cardiac tissue fibrosis evaluation. Masson’s trichrome staining sections were analyzed by optical microscopy to evaluate perivascular and interstitial
fibrosis in the LV myocardium (greenish). Representative images of heart sections from control (a and b) and TiO2-NP treated animals (c and d). a CTRL LV
myocardium; black rectangle area is shown at higher magnification in panel (b). c TiO2-NPs treated LV myocardium; black rectangle area is shown at
higher magnification in panel (d). Scale bars: a and c= 200 μm; b and d= 100 μm
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compared to CTRL (Fig. 9b-d). Interestingly, at the same
time point, also TGF-β1 (transforming growth factor beta-
1) and CTGF (connective tissue growth factor) showed sig-
nificantly increased expression (Fig. 9e and f).
Discussion
Inhaled NPs are on the current concern for their effect
on the cardiovascular system after translocation from
the air-blood barrier [23]. Evidences are provided for in-
haled NPs accumulation in the sites of vascular lesions
[24], lymph nodes, liver, kidneys [25] and the heart [4].
Ambient (indoor) air pollution, due to the rapid
urbanization worldwide, is known to be an important
trigger of cardiovascular diseases especially for the
people/workers that exposed continuously to NPs emit-
ting sources with poor ventilation [26]. Following our
Fig. 6 Ultrastructural features of the alveolar lung parenchyma from a representative untreated CTRL and TiO2-NPs treated SHR. a a type I pneumocyte
(PI) and three capillaries (*) are present in the alveolar septum separating air spaces (As) in CTRL lung. b several TiO2-NPs are present in the cytoplasm
of a large alveolar macrophage showing, in addition to vacuoles and microvescicles, onionskin-like multimembrane ultrastructures suggestive of
autophagy. The area inscribed by white rectangle is shown at higher magnification in the inset. c an aggregate of electrondense TiO2-NPs is located
nearby an endothelial cell lining the lumen of a capillary recognizable by the red blood cell (RBC). The white rectangle inscribes an area shown at higher
magnification in d to document that TiO2-NPs are not yet internalized. e internalization of TiO2-NPs in a capillary endothelial cell that is better appreciable
at higher magnification in (f). Scale Bars: a 5 μm, b, c, e: 2 μm, d, f: 500 nm
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recent findings that showed inhaled TiO2 NPs in the
heart [19], recent literature have shown that inhaled ti-
tanium dioxide NPs activate a plethora of cardiovascular
effects, i.e., activation of complement cascade in the
heart [27], induction of cytotoxicity in cardiomyoblast
[28], microvascular and mitochondrial dysfunction in
progeny of female SD rats exposed to TiO2 [29],
induction of myocarditis [30] and depression diastolic
function in response to adrenergic stimuli [31].
In this study, we observed two concomitant responses
in terms of both electrical remodeling (reversible) and
mechanical and structural remodeling (irreversible) in
SHRs subjected to 2 mg/kg TiO2 weekly repeated tra-
cheal instillation compared with saline treated animals.
Fig. 7 TEM analysis of the heart from a representative untreated CTRL and TiO2-NP treated SHR. a low magnification image of a CTRL heart to illustrate
the sarcolemma (arrowheads) lining the surface and gap junctions (arrows) delimiting cardiomyocytes filled of mitochondria and myofibrils. On the
left, collagen bundles (Col) are present in the interstitial space between an endothelial cell (Ec) lining a capillary lumen (L) and cardiomyocytes. N:
cardiomyocyte nucleus. b aggregates of TiO2-NPs within the cardiomyocyte cytoplasm showing effaced myofibrils and swollen mitochondria. c the white
rectangle inscribes an area shown at higher magnification in (d) in which the arrowhead points to NP located in the interstitial space between the vessel
wall inscribing a lumen (L) and cardiomyocytes (CM). e low magnification image of a treated SHR myocardium to illustrate widening of the interstitial
space by abundant fibrotic deposition (Col) surrounding cardiomyocytes (CM) and an endothelial cell (Ec) lining a capillary. Arrowheads point to gap
junctions delimiting two CMs. The white rectangle inscribes an area shown at higher magnification in f to document the internalization of TiO2-NP located
in proximity of the CM sarcolemma bordered by collagen bundles (Col). Scale Bars: A, C, E: 5 μm, B: 2 μm, D: 1 μm, F: 500 nm
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Electrical remodeling
The electrical remodeling is related to a direct interaction
between TiO2-NPs and cardiac cell membrane. The elec-
trical remodelling and the arrhythmic events are related to
a direct interaction between TiO2-NPs and cardiac cell
membrane via ionic leakage as previously described [19].
The almost complete recovery of electrical functional
properties, can be explain by the recruitment and presence
of myofibroblasts that can concur in entrapping TiO2-NPs
in the interstitial regions and thus reduced the amount of
NPs passing the cardiomyocytes cell membrane (cf. Fig-
ure 7d). Because of that, the subsequent depolarization is
now minimal but enough for enhancing excitability. The
latter is the base of the biophysical phenomena of super-
normal (increment) conduction velocity as described by us
in fibrotic engineered in-vitro cardiac tissue [32] and in
normotensive animals subjected to a single instillation of
TiO2-NPs [19].
Noteworthy, in treated SHRs, only the number of hypo-
kinetic arrhythmic events, including SP events (correlating
with altered P wave duration) and AV blocks, as well as
inducible arrhythmic events significantly increased at the
6th week and completely terminated at the end of the
treatment. This scenario is presumably due to cardiac tis-
sue damage associated with a direct acute effect of NPs,
further confirmed here by ultrastructural analysis. Import-
antly, the number of arrhythmic events in the treated
animals (sinus pauses and AV blocks) was significantly
reduced approaching the values observed in CTRL (saline,
positive control).
Conversely, neither the NPs treatment nor the sub-
chronic exposure influenced QRS complex. Neverthe-
less, RR variability increased in both groups at the end
of treatment, suggesting a time-dependency effect of this
parameters independently of the treatment.
Mechanical and structural irreversible remodeling
The irreversible mechanical and structural remodeling is
related to the subchronic exposure to TiO2-NPs that
causes in SHRs a series of maladaptive cardiac responses
mainly characterized by inflammation, upregulation of
genes promoting collagen deposition and fibrosis, ultim-
ately leading to alterations in hemodynamic performance.
Electrocardiographic measurements in freely moving
animals demonstrated a time-dependency for P wave
duration (6th and 7th weeks) and RR interval (7th
weeks). We are unable to interpret this finding and fur-
ther specific atrial electrophysiological and morpho-
logical measurements are required.
Epicardial multiple lead recording demonstrated a de-
crease in the CVl only after the first NPs instillation,
possibly due to a massive depolarization of the resting
potential created by the NPs entry in the cardiac tissue
[20]. It is known that SHR cardiomyocytes have a reduc-
tion in IK1 current responsible for diastolic membrane
potential depolarization [33], and thus modulating
a c
b d
Fig. 8 Inflammation and toxicological markers in the heart tissue. Lipid peroxidation products and different inflammatory and toxicological markers
evaluated in CTRL (white bars) and TiO2-NPs treated (black bars) animals. a TBARS evaluation in the heart tissue. b IL-6 evaluation in the heart tissue r. c
MCP-1 evaluation in the heart tissue. d TIMP-1 evaluation in the heart tissue. Two-way ANOVA (post hoc analyses: Bonferroni test) was performed and
statistical significance was set at p< 0.05. ● vs CTRL; * vs corresponding 1° week; # vs corresponding 3° week. Data are represented as mean ± SEM
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cardiac excitability. Moreover, the treated animals de-
noted a major time-dependency because at the 6th week,
we observed a significant increment in CVl and CVt in
the treated group vs. CTRL, at the first and third week.
Such increment disappeared at the 7th week after the
“washout” period. The increment at the 6th week can be
explained if we take into account two factors: i) the CVs
are calculated only for portions of the epicardial multiple
lead arrays that denoted absence of conduction blocks
and ii) a role exerted by the cardiac myofibroblasts that
are populating the fibrotic tissue.
Repeated exposure to TiO2-NPs doubled the total
amount of cardiac fibrosis and triplicated the diffuse
fibrosis known to fasten the progression towards heart
failure [34]. These findings are in agreement with the sig-
nificant upregulation of genes involved in (myo)fibroblast
recruitment and collagen protein expression: TGF-β1 and
COL1A2 (threefold increment), COL3A1 and CTGF (six-
fold increment), COL4A1 (fivefold increment). Those
genes were upregulated exactly at the third week of instil-
lation, when also the inflammatory response initiated in
the heart. Indeed, the third week of exposure is the critical
time-point, when we observed the increment in oxidative
stress markers and cytokines in cardiac tissue in agree-
ment with Gurguiera et al. [35] showing that heart oxida-




Fig. 9 Molecular analysis displaying different gene expression linked to fibrosis deposition. Graph of different gene expression in CRTL (triangles) and TiO2-
NPs treated (square) animals. a ACTA2 gene expression; b COL1A2 gene expression; c COL3A1 gene expression; d COL4A1 gene expression; e TGF-β1
gene expression; f CTGF gene expression. Kruskal-Wallis (post hoc analyses: Dunn’s multiple comparison) was performed and statistical significance was set
at p< 0.05. ● vs CTRL; * vs corresponding 1° week; # vs corresponding 3° week. Data are represented as median and IQR
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compared with others elemental components. Tissue in-
hibitor of metalloproteinase-1 (TIMP-1), known to pro-
mote myocardial fibrosis [36, 37], was also significantly
upregulated at the third week compared to its control at
the same time and compared to the 1st week of treatment,
consistently with the significant upregulation of the re-
lated collagen-isoform genes.
Overall, the co-existence of hypertension and nanopar-
ticle exposure leading to structural tissue damage can be
responsible for the majority of alterations in gross car-
diac characteristics, including chamber dilation and re-
duction in LV mass, as well as worsening of cardiac
hemodynamic performance.
Conclusions
The comorbidity of hypertension and inhaled nanoparti-
cles has been largely studied in terms of hazard at epi-
demiological and meta-analysis levels. We provide here,
for the first time, a mechanistic evidence that this co-
morbidity induces irreversible hemodynamic impairment
associated with cardiac structural damage, while electro-
physiological alterations are mostly reversible. Translat-
ing this animal-based data to human hypertension is
questionable due to species-related differences, different
adaptation to the pathology and treatment, and the pro-
cedure we adopted for tracheal administration. Never-
theless, we provided here experimental evidence that the
most produced engineered nanomaterial, considered to
be inert, activates functional and structural remodelling
of the hypertensive heart, potentially fastening the pro-
gression towards cardiac failure. Specifically, our results
indicate that prolonged TiO2-NP exposure may reach a
point of no-return (third week of treatment), in terms of
myocardial tissue damage and reduces cardiac mechan-
ical efficiency. This needs to be considered for the vul-
nerable subjects/workers daily exposed to nanomaterials.
Limitations
Invasive hemodynamic and morphological measure-
ments have been acquired only at the end of the treat-
ment. On the other hand, it should be considered that
the upregulation of genes promoting fibrotic damage
and inflammation occurred at the third week and this
finding prompted us to focus on the consequent later
morphofunctional irreversible changes.
In this study, we limited our investigation to the ven-
tricular cardiac fibrosis as one of the leading causes to-
wards heart failure, in both NP-treated and untreated SHR.
However, similar investigations need to be addressed for a
plethora of hypertension-related diseases including atrial
dysfunction, vascular endothelial dysfunction and pulmon-
ary responses and clearance, known to be primary barriers
for the inhalator route of nanoparticles. Lastly, we included
here only one risk factor (i.e. hypertension) impacting only
for a minimal period of the life course (adulthood).
Methods
Experimental animals
Experiments were conducted on sixty-four 12-week-old
Spontaneously Hypertensive male rats (Envigo, Hunting-
don, United Kingdom, SHR, Harlan Laboratories s.r.l.,
Italy) singly housed with the light on between 7 a.m. and
7 p.m. in a temperature-controlled room at 22–24 °C.
The bedding of the cages consisted of wood shavings
with food and water available ad libitum. All surgery
procedures and experiments, when specified, were per-
formed under anesthesia which consisted of a mixture of
ketamine chloride (40 mg/kg ip; Imalgene, Merial, Mi-
lano, Italy) and medetomidine hydrochloride (0.15 mg/
kg ip; Domitor, Pfizer Italia s.r.l., Latina, Italy). The
period of study was selected by taking into consideration
the frailty of SHR animals and their suffering due to the
hypertensive condition. This study was carried out in ac-
cordance with the recommendations in the Guide for
the Care and Use of Laboratory Animals of the National
Institute of Health (Bethesda, MD, USA, revised 1996).
The protocol was approved by the Veterinary Animal
Care and Use Committee of the University of Parma
(Permit: n. PMS 53/2009) and conforms to the National
Ethical Guidelines of the Italian Ministry of Health. All
effort was made to minimize suffering. We noticed 15%
of spontaneous animal loss during the repeated
anesthesia procedures from the 3rd week onwards be-
cause of the SHR hyperreactivity [38]. We did not ob-
serve animal loss for the surgical procedure.
Particle suspension
TiO2-NPs (Titanium (IV) oxide, code 677469, Sigma-
Aldrich, Milan, Italy) were previously characterized by
us [19, 39]. Nanoparticles were suspended in physio-
logical saline solution (10 mg/mL, stock solution). Im-
mediately before the experiments, the suspension was
vortexed and immersed in a sonication bath (Branson
Ultrasonics, Danbury, CT, USA) for 5 min at 37 °C in
order to minimize particle aggregation.
Intra-tracheal instillation
Although inhalation studies are considered to be the gold
standard, data from intra-tracheal instillation studies can be
used for hazard assessment [16]. The instillation process
was extensively described in our previous work [19]. Briefly,
after anesthesia, a 16-gauge catheter was gently inserted
into the trachea of rats in order to deliver 20 μL/100 g BW
of saline solution or saline solution plus 2mg/kg TiO2 by
means of a laboratory bench P200 pipette (Gilson, Dun-
stable, UK). We adopted repeated weekly doses of 2mg/kg
by taking into consideration the NIOSH recommendation
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(https://www.cdc.gov/niosh/docs/2011-160/pdfs/2011-160.
pdf) of 0.3mg/m3 of TiO2 NPs exposure as time-weighted
average concentration for 10 h per day during 40-h work
week and the species-specificity [19]. With such a concen-
tration we are further beneath the maximal exposure limit
for both human [40] and rats [41–43]. Furthermore, an
empty sterile syringe (1mL) was used to gradually inflate
the lung with air twice prior to the connection of the can-
nula port to a ventilator (Rodent ventilator UB 7025, Ugo
Basile, Comerio, Italy) set to 85 cycle/min. Finally, admin-
istration of 0.15mg/kg atipamezole hydrochloride (Antise-
dan, Pfizer, Milan, Italy) has been performed to wake up
the animal. This protocol was repeated consecutively once
a week for 6 weeks. A six-week period was selected be-
cause the SHR at this stage of age had an average systolic
blood pressure of 200mmHg, and we choose 7 weeks as
longitudinal study in order to avoid physical suffering due
to high systolic blood pressure and aged related cardiac
implication [44].
Outline of the experimental protocols
Telemetry-ECG, hemodynamic, cardiac anatomy and
morphometry studies
The experimental design and measurements performed in
the two experimental groups are summarized in Fig. 1. Six-
teen rats were chronically instrumented with a telemetry-
ECG system to enable the evaluation of arrhythmia
vulnerability and the duration of the different ECG waves
and intervals, in conscious freely moving animals. One
week later, the animals started the experimental instillation
protocol which consisted in a weekly intra-tracheal instilla-
tion of saline solution (CTRL group, n = 8) or saline solu-
tion added with TiO2 at a final concentration of 2mg/kg
(TiO2-NP group, n = 8), as described above. Four hours
later, a 30-min telemetry-ECG recording was performed
while the experimental animal was left alone and undis-
turbed in its cage. ECG recordings were also performed at
the 3rd week, 6th week, and at the end of the experimental
protocol (7th week) 1 week after the last intra-tracheal in-
stillation (Fig. 1). Afterward, hemodynamic data were inva-
sively collected in all animals and in additional 3 TiO2-NP
and 1 CTRL rats for a total of 11 TiO2-NP and 9 CTRL. Fi-
nally, at sacrifice, the hearts were perfusion fixed for ana-
tomical and structural studies.
Epicardial multiple-lead recording, PIXE, and molecular
studies
In 38 rats belonging to CTRL (n = 16) and TiO2-NP
(n = 22) groups, electrophysiological investigation was
performed by epicardial multiple-lead recording at the
same time points specified above for telemetry-ECG re-
cordings. At death, for each time point, fresh prepara-
tions of the excised hearts and lungs were used for
molecular analyses (real time PCR: n = 3 CTRL, n = 5
TiO2-NP), immunological assay (n = 3 CTRL and n = 4
TiO2-NP) while for TiO2-NP quantification (PIXE, see
specific section below for details) the analysis has been
performed at the 1st week (n = 3 TiO2-NP) and at the
end of the treatment, 7th week (n = 2 TiO2-NP).
Transmission electron microscopy study
In 3 CTRL and 3 TiO2-NP rats, heart and lung samples
were analyzed by TEM in order to document the presence
of NPs within these tissues at the end of the experimental
protocol (7th week), 1 week after the 6th intra-tracheal in-
stillation, given that we have already documented the
presence of TiO2-NPs in both tissues 4 hours after tra-
cheal instillation [15].
Animal instrumentation for telemetry-ECG recording
After anesthesia, animals were chronically instrumented
with a miniaturized transmitter for telemetry-ECG record-
ing (model TA11CTA-F40, Data Sciences International,
St. Paul, MN, USA). The details of the surgical procedure
have been already published by us [45]. Briefly, a ventral
celiotomy was performed and the body of the transmitter
(25x15x8mm) was placed in the abdominal cavity. One re-
cording lead was fixed to the dorsal aspect of the xiphoid
process, close to the apex of the heart. The other lead was
subcutaneously tunneled on the thorax toward the upper
insertion of the sternohyoid muscle. Here, the wire was
formed into a U shape, pushed under the muscle and then
along the trachea into the anterior mediastinum, to get
the tip of the recording lead close to the right atrium. Fi-
nally, the muscle and skin layers were separately sutured.
After surgery, all animals were given Antisedan 0.15mg/
kg im (Pfizer), flunixin 5mg/kg im (Finadyne, Schering-
Plough s.p.a, Milan, Italy), gentamicin sulphate 10mg/kg
im (Aagent, Fatro, Milan, Italy), and kept warm with infra-
red lamp radiation. Antibiotic therapy was continued in
the following 3 days while the animals were individually
housed. Rats were allowed to recover for 7 days before the
onset of the instillation protocol and ECG acquisition.
Telemetry-ECG data acquisition and processing
ECG signals were collected by a receiver (model CTR85-
SA, Data Sciences International, St. Paul, MN, USA)
placed under the housing cage, monitored on an oscillo-
scope and simultaneously routed to a personal computer,
via an analog-to-digital conversion board (12 bits, 1 kHz
sampling rate), for a permanent storage. The data were
analyzed by using a software package developed in our
laboratory, in order to measure:
i. RR interval duration, the time interval between
two consecutive R wave peaks;
ii. P wave duration (atrial depolarization), between
the onset and offset of P wave;
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iii. PQ interval, the time interval between the onset of
P wave and the onset of QRS complex (ventricular
depolarization);
iv. QRS complex duration;
v. QT interval, the time interval between the onset of
QRS complex and the end of T wave (ventricular
repolarization);
vi. QTc interval, heart rate-corrected QT interval
(Bazett’s formula);
vii. Heart rate variability. The indexes of heart rate
variability included: the SDRR and r-MSSD, which
quantify the state of the balance between sympa-
thetic and parasympathetic activities on the heart
and the influence on heart rate of the parasympa-
thetic branch respectively [46];
viii.Number and type of arrhythmic events. In detail,
we recorded both, supraventricular
(Supraventricular Extrasystole and Sinus
Arrhythmia, SVA; SP) and ventricular (AV block;
Ventricular Extrasystole, VE) events.
For the evaluation of ECG wave and interval duration,
30 measures for each animal were performed.
Hemodynamic study
After anesthesia, the right carotid was cannulated with a
microtip pressure transducer catheter (Millar SPC-320;
Millar Instruments, Houston, TX, U.S.A.) connected to a
recording system (Power Laboratory ML 845/4 channels;
2Biological Instruments, Besozzo, Italy), and systolic and
diastolic arterial blood pressures were determined. The
catheter was then advanced into the left ventricle to meas-
ure (software package CHART B4.2): LVSP; LVEDP; +dP/
dtmax and -dP/dtmax, taken as indexes of ventricular mech-
anical efficiency; IVCT.
Tibial length, cardiac anatomy and morphometric analysis
At the end of the hemodynamic procedure, the heart was
arrested in diastole by injecting 5mL of cadmium chloride
solution (100mmol/L, iv), and excised. The right ventricle
and the left ventricle inclusive of the septum were separ-
ately weighed and fixed in 10% buffered formalin solution.
In all animals, the length of the tibia was also determined.
The volume of the LV myocardium was computed by div-
iding LV weight by the specific gravity of the tissue (1.06
g/mL). LV chamber length was measured from the apex to
the aortic valve. The equatorial transverse section of the
left ventricle (1mm thick), cut perpendicularly to the
major axis, allowed the morphometric computation of the
LV equatorial diameter and wall thickness (Image Pro-
plus, Media Cybernetics, Bethesda, MD, USA, version 7.0).
The LV chamber volume was then calculated according to
the Dodge equation, which equalizes the ventricular cavity
to an ellipsoid [47]. The section was finally embedded in
paraffin. Five-micrometer-thick serial sections were ob-
tained from the equatorial slice and used for morphomet-
ric analyses. One section, stained with blue aniline
Masson’s trichrome, was analyzed by optical microscopy
(magnification X 250) to evaluate the volume fraction of
perivascular and interstitial fibrosis in the LV myocar-
dium. According to a procedure previously described [48],
for each section a quantitative evaluation of the fibrotic
tissue was performed in 60 consecutive fields from suben-
docardium, midmyocardium, and subepicardium with the
aid of a grid defining a tissue area of 0.160mm2 and con-
taining 42 sampling points, each covering an area of
0.0038mm2. To define the volume fraction of fibrosis, the
number of points overlying myocardial fibrosis was
counted and expressed as percentage of the total number
of points explored.
Epicardial multiple-lead recording
In rats under anesthesia and artificial respiration, the heart
was exposed through a longitudinal sternotomy and sus-
pended in a pericardial cradle. Body temperature was
maintained with infrared lamp radiation. An 8 × 8 row
electrode matrix with 1-mm inter-nodal resolution was
fabricated from surgical cotton gauze. The electrode array
was positioned in order to cover part of the anterior sur-
face of the right and left ventricles [49], and the following
measurements were carried out: refractoriness (by means
of S1-S2 protocol) and inducible ectopic activity (n = 8 for
each animal), ventricular excitability (Rheobase and
Chronaxie, n = 5 for each animal and Threshold intensity
for a 1ms duration impulse, n = 13) and conduction vel-
ocities (CVl and CVt, n = 10 for each animal, as well as
their ratio), as previously described [19]. Moreover,
arrhythmia inducibility was evaluated as percentage of
electrodes showing at least one ventricular extrasystole
during effective refractory period (ERP) protocol.
Titanium dioxide quantification by PIXE
The trachea, lungs, and heart were prepared into pellets
following the previously described procedure [50].
Briefly, biological samples were dried in a 37 °C oven for
24 h, then they were freeze dried and chromium nitride
(Cr2N) powder (Goodfellow SARL, Lille, France) was
added at 8.5 ± 1.5 wt.%. Biological samples and Cr2N
powder were ball milled to produce a homogeneous
powder mixture which was hard pressed into a 2 cm
diameter, 1-2 mm thick pellet. We added Cr2N in order
to avoid charge accumulation in the sample during ion
beam irradiation and have an internal beam monitor for
quantitative measurements. In addition, Cr2N does not
interfere with the measurement of other elements, be-
cause it is neither present in the biological matter nor as
an impurity in TiO2.
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PIXE measurements were performed with the University
of Namur ALTAÏS accelerator (Accélérateur Linéaire Tan-
detron pour l’Analyse et l’Implantation des Solides). PIXE
is an ion beam technique, whose physical principles can be
found extensively explained elsewhere [51], providing pre-
cise quantification of chemical elements in toxicological
assessments [52]. PIXE and Rutherford Back-scattering
(RBS) measurements were done simultaneously with an in-
cident ion beam of 2.5MeV protons with an intensity of
1–1.5 nA. With respect to the beam direction, the sample
was tilted at 45°, a Canberra LEGe (Low Energy Germa-
nium) detector was located at 90° for PIXE measurements
(variable solid angle up to 35 msr), and a Canberra PIPS
(Passivated Implanted Planar Silicon) detector was posi-
tioned at 145° for RBS measurements (solid angle of
23.8 msr). An aluminum collimator (1mm aperture, 0.2
mm thick) was used in front of the PIXE detector to
equalize the ratio of low-energy and high-energy X-rays.
The samples were mounted on a rotating device providing
a total analyzed area of 140.5 mm2. RBS was used to derive
the number of incident ions, and to quantify carbon, oxy-
gen and nitrogen contents for matrix (lung tissue) correc-
tion of X-ray absorption effects. A BCR-126 lead glass
standard was used to calibrate both detectors. The PIXE
setup allowed for a detection limit of Ti in biological
matrices of 10 wt.ppm [52].
Data were analyzed with the GUPIXWIN software [53].
The concentration of TiO2-NPs in tissues was calculated
from the Ti X-ray emission, then converted to TiO2 assum-
ing a 1:2 ratio of Ti:O.
Oxidative stress and inflammation
Tissue samples were washed with PBS and included in
cryovials prior to freezing at − 80 °C. Frozen tissue samples
(lungs, and heart) were homogenized and sonicated in PBS
supplemented with protease inhibitor cocktail (Sigma-Al-
drich, Milan, Italy). Insoluble debris was pelleted and super-
natants were analyzed.
Lipid peroxidation was evaluated by TBARS method,
using Malondialdehyde as a standard for the calibration
curve [39]. The fluorescence intensity was measured by
Cary Eclipse fluorescence spectrophotometer (Varian/Agi-
lent, Santa Clara, CA, USA) (excitation 515 nm, emission
545 nm). Four independent experiments were carried out
and TBARS values were normalized to protein concentra-
tions. Commercially available enzyme-linked immunosorb-
ent assays (ELISA, Cloud-Clone Corp., Katy, TX, USA)
were used to evaluate biomarkers of tissue inflammation
(IL-6 and MCP-1), and tissue remodeling (TIMP-1). All
data were related to protein concentration.
Real-time PCR analysis
Frozen heart samples were kept in dry ice and cut into
small pieces of about 50–70mg using a scalpel. TRIzol
reagent (1ml) (Invitrogen, Thermos Fisher Scientific) was
then added to each sample, and the tissue was homoge-
nized using the TeSeE PRECESS 24 (BioRad) performing
three agitation cycles at 5100 rpm for 10s at 4 °C. Homog-
enized tissues were centrifuged at 12000×g for 1min, in
order to remove particulate debris. The RNA was subse-
quently extracted from the supernatants using the kit
Direct-zol RNA MiniPrep (Zymo research), following
manufacturer’s instructions.
RNA concentration and quality was assessed by Nano-
Drop 1000 spectrophotometer (Thermo fisher Scientific):
only samples with a value of A260/280 > 1.8 and A260/
230 > 1.8 were used for subsequent gene expression ana-
lysis. RNA integrity was evaluated with Experion electro-
phoresis system using the Experion™RNA StdSens Analysis
Kit (Bio-Rad).
Total RNA (1 μg) was reversely-transcribed using the
SuperScript VILO cDNA synthesis Kit (Thermo Fisher
Scientific) according to manufacturer’s instructions.
The amplification of the cDNA was then performed
using All-in-One SYBR® Green qPCR Mix (GeneCo-
poeia) on a CFx96 Real-Time System C1000 Thermal
Cycler (BioRad). The list of primers used for cDNA
amplification is reported in Additional file 4: Table S1.
Raw expression intensities of genes of interest were nor-
malized to the Ct value of Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH). Relative quantitation was per-
formed using the ΔΔCt method in comparison with the
mean expression of the same genes in CTRL animals. Fold
changes in gene expression were calculated as 2 (ΔΔCt) [54].
Titanium dioxide detection in heart and lung tissues by
TEM
Heart and lung samples from 3 CTRL and 3 TiO2-NP
groups at the 7th week of the experimental protocol, 1
week after the last intra-tracheal instillation, were ana-
lyzed by TEM in order to document the presence of
NPs within these tissues. Samples were fixed in Kar-
novsky solution (4% formaldehyde, 5% glutaraldehyde)
for 3 h at room temperature. After washing several times
with 0.1M phosphate buffer, pH 7.2, the tissues were
post-fixed in 1% osmium tetroxide (OsO4) for 90 min at
room temperature and dehydrated by increasing concen-
tration of alcohol. Then, samples were washed with
propylene oxide and embedded in epoxy resin. Sections
of 0.5 μm thickness were stained with methylene blue
and safranin to morphologically select the field of inter-
est. Subsequently, ultrathin sections of 60-80 nm thick-
ness were collected on a 300-mesh copper grid and,
after staining with uranyl acetate and lead citrate, were
qualitatively examined under a transmission electron
microscope (EM 208S model, Philips, Amsterdam, The
Netherlands).
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Statistical analysis
Data were expressed as median and interquartile range
(IQR), except for the hemodynamic and morphometric
parameters (Tables 1 and 2) and oxidative stress and in-
flammation (Fig. 8) that were reported as means ± stand-
ard error of the mean (SEM). Normal distribution of
variables was checked by means of the Kolmogorov-
Smirnov test. Statistics of variables included unpaired
Student’s t-test, two-way ANOVA (post hoc analyses: Bon-
ferroni test or Games-Howell test, when appropriate) and
Kruskal-Wallis (post hoc analyses: Dunn’s multiple com-
parison). Prism 5.0 software (GraphPad Software) was
used to assess the normality of the data and for statistical
calculation. The details on the specific test used for each
experiment are reported in the figure legends. Statistical
significance was set at p < 0.05.
Additional files
Additional file 1: Figure S1. Spontaneous arrhythmic events. Different
examples of arrhythmic events. Both, supraventricular (Supraventricular
Extrasystole and Sinus Arrhythmia, SVA; Sinus Pause, SP) and ventricular (Atrio-
ventricular block, AV block; Ventricular Extrasystole, VE) events were recorded.
(PDF 324 kb)
Additional file 2: Figure S2. TEM analysis of the alveolar lung parenchyma
from a SHR rat seven weeks after intratracheal instillation of TiO2-NPs. Individual
or microaggregates of small electrondense NPs are present in the air space (As)
as scattered within the alveolar septum in which a type II pneumocyte (PII) is
recognized. NPs are also apparent in endothelial cells lining a capillary (*) and the
lumen of a larger venule containing red blood cells (RBC) polymorphonuclear
(PMN) neutrophils, lymphocytes (Lym) and platelets (arrow). Magnification 1800X.
Scale Bar: 10μm. (PDF 2011 kb)
Additional file 3: Figure S3. TBARS measurement in lungs evaluated in
CTRL (white bars) and TiO2-NPs treated (black bars) animals. Two-way ANOVA
(post hoc analyses: Bonferroni test) was performed and statistical significance
was set at p<0.05. ● vs CTRL; * vs corresponding 1° week; # vs corresponding
3° week. Data are represented as mean ± SEM. (PDF 60 kb)
Additional file 4: Table S1. List of primer sequences 5′-3′ used for real-
time PCR analysis. (PDF 118 kb)
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